GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinocelltech Group Ltd (SHSE:688520) » Definitions » Additional Paid-In Capital

Sinocelltech Group (SHSE:688520) Additional Paid-In Capital : ¥0 Mil(As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Sinocelltech Group Additional Paid-In Capital?


Sinocelltech Group's quarterly additional paid-in capital increased from Sep. 2024 (¥0 Mil) to Dec. 2024 (¥2,239 Mil) but then stayed the same from Dec. 2024 (¥2,239 Mil) to Mar. 2025 (¥0 Mil).

Sinocelltech Group's annual additional paid-in capital stayed the same from Dec. 2022 (¥2,239 Mil) to Dec. 2023 (¥2,239 Mil) and stayed the same from Dec. 2023 (¥2,239 Mil) to Dec. 2024 (¥2,239 Mil).


Sinocelltech Group Additional Paid-In Capital Historical Data

The historical data trend for Sinocelltech Group's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinocelltech Group Additional Paid-In Capital Chart

Sinocelltech Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only 1,777.08 1,777.08 2,238.51 2,238.51 2,238.51

Sinocelltech Group Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 2,238.51 - 2,238.51 -

Sinocelltech Group Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Sinocelltech Group Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Sinocelltech Group's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinocelltech Group Business Description

Traded in Other Exchanges
N/A
Address
Kechuang Seventh Street, Beijing Economic and Technological Development Zone, Room 307, Building 5, Courtyard 31, Beijing, CHN, 100176
Sinocelltech Group Ltd is engaged in development and industrialization of biopharmaceutical products such as monoclonal antibodies, recombinant proteins and vaccines. The company has developed technology platforms in protein expression vectors, cell line development, serum-free medium development, stoichiometrically controlled fed-batch cell culture, process scale-up, and protein purification. Its capacities include stable CHO cell line development, cell banking and certification, serum-free and protein-free culture medium development, fed-batch cell culture process development, optimization, and process scale-up; protein purification development, and large scale production.
Executives
Xie Liang Zhi Director

Sinocelltech Group Headlines

No Headlines